Evidence map›Paper›PMID 36535642›Full record

ArticleJournal of the American Chemical Society2023

Cyclic Diaryl λ

Matteo Lanzi, Torben Rogge, Tan Sang Truong, K N Houk, Joanna Wencel-Delord

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. One-pot divergent synthesis of 5-arylmethyl oxazoles and polyacenes from propargylic amides and arynes.Organic chemistry frontiers : an international journal of organic chemistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CspChemical science · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Aryne-Enabled C-N Arylation of Anilines.Angewandte Chemie (International ed. in English) · 2023
    Article
  15. Cyclic Homo- and Heterohalogen Di-λJournal of the American Chemical Society · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matteo LanziLaboratoire d'Innovation Moléculaire et Applications (UMR CNRS 7042), Université de Strasbourg/Université de Haute Alsace, ECPM, 67087Strasbourg, France.
Torben RoggeDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California90095, United States.ORCID 0000-0002-4519-4596
Tan Sang TruongLaboratoire d'Innovation Moléculaire et Applications (UMR CNRS 7042), Université de Strasbourg/Université de Haute Alsace, ECPM, 67087Strasbourg, France.
K N HoukDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California90095, United States.ORCID 0000-0002-8387-5261
Joanna Wencel-DelordLaboratoire d'Innovation Moléculaire et Applications (UMR CNRS 7042), Université de Strasbourg/Université de Haute Alsace, ECPM, 67087Strasbourg, France.ORCID 0000-0002-7094-5443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypervalent chloranes are a class of rare and poorly explored reagents. Their unique electronic properties confer reactivity that is complementary to that of the common iodanes and emerging bromanes. Highly chemo- and regioselective, metal-free, and mild C-C and C-O couplings are reported here. Experimental and computational mechanistic studies elucidate the unprecedented reactivities and selectivities of these systems and the intermediacy of aryne intermediates. The synthetic potential of these transformations is further demonstrated

Indexed as

PhenolsIndicators and ReagentsIndicators and ReagentsPhenols

Identifiers

PMID36535642
PMCPMC9837845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.